Rufus Collea

Hematology | Oncology
3 Crossing Blvd Ste 1
Clifton Park, NY 12065

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications

Transitions in cancer care-moving from crisis intervention to care planning and management.

Transitions in cancer care-moving from crisis intervention to care planning and management.

Journal: The American journal of managed care
Published: September 09, 2017

Five-year results of a phase II trial of preoperative 5-fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2-positive patients) for patients with stage II or III breast cancer.

Five-year results of a phase II trial of preoperative 5-fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2-positive patients) for patients with stage II or III breast cancer.

Journal: Cancer medicine
Published: April 26, 2017

Incidence and Predictive Factors for Recovery of Ovarian Function in Amenorrheic Women in Their 40s Treated With Letrozole.

Incidence and Predictive Factors for Recovery of Ovarian Function in Amenorrheic Women in Their 40s Treated With Letrozole.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 18, 2016

Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study.

Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study.

Journal: The Lancet. Oncology
Published: September 07, 2013

Pegylated liposomal doxorubicin plus carboplatin in patients with metastatic breast cancer: a phase II study.

Pegylated liposomal doxorubicin plus carboplatin in patients with metastatic breast cancer: a phase II study.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 21, 2012
Showing 1-5 of 5

Last Updated: 09/26/2026